Observational study on gastrointestinal diseases in Los Angeles
Prospective Evaluation of Pancreatic, Biliary, and Gastrointestinal Neoplasia by Endoscopic Retrograde Cholangiopancreatography (ERCP) and Endoscopic Ultrasound (EUS)
This study looks at patients in Los Angeles with gastrointestinal issues to see how well certain procedures work for diagnosing and treating problems like bile duct stones and cancers.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 2500 (estimated) |
| Sex | All |
| Sponsor | University of Southern California Academic / other |
| Locations | 1 site (Los Angeles, California) |
| Trial ID | NCT02196935 on ClinicalTrials.gov |
What this trial studies
This study aims to collect and analyze data from patients undergoing endoscopic retrograde cholangiopancreatography (ERCP) and endoscopic ultrasound (EUS) at Los Angeles County Hospital. It focuses on understanding the biochemical, radiographic, and clinical predictors of bile duct stones, as well as the management of cholangitis, bile leaks, and gastrointestinal cancers in an underserved population. The study will prospectively record patient presentations, procedural outcomes, and subsequent clinical courses to evaluate the effectiveness of these endoscopic techniques. Additionally, it will compare the results of EUS and ERCP with other imaging methods.
Who should consider this trial
Good fit: Ideal candidates include patients undergoing EUS or ERCP at Los Angeles County Hospital.
Not a fit: Patients not requiring EUS or ERCP procedures will likely not benefit from this study.
Why it matters
Potential benefit: If successful, this study could improve the management and outcomes of patients with biliary diseases and pancreatic conditions.
How similar studies have performed: Other studies have shown success with similar approaches in understanding the role of EUS and ERCP in managing gastrointestinal diseases.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * All patients undergoing EUS or ERCP at LAC, UH, and Norris Cancer Hospitals as standard of clinical care will be enrolled. Exclusion Criteria: * None of the patients will be excluded.
Where this trial is running
Los Angeles, California
- Los Angeles County Hospital — Los Angeles, California, United States (Recruiting)
Study contacts
- Principal investigator: James L Buxbaum, MD — University of Southern California School of Medicine
- Study coordinator: James Buxbaum, MD
- Email: jbuxbaum@usc.edu
- Phone: 3234096939
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.